• SENSEX 80,567.71
    409.83 (+0.51%)
  • BANKNIFTY 54,067.55
    406.55 (+0.76%)
  • Ola Electric
    70.25 123.90(%)
  • N S D L
    1,236.20 880.00(%)
  • Aditya Vision
    447.00 328.25(%)
  • Vimta Labs
    829.00 787.20(%)
  • One Mobikwik
    300.00 698.30(%)
  • Tata Steel
    168.00 170.20(%)
  • Netweb Technol.
    2,564.75 3,060.00(%)
  • Apollo Micro Sys
    306.60 298.70(%)
  • Aurobindo Pharma
    1,041.00 1,592.55(%)
  • Jai Corp
    170.15 406.00(%)
  • Moschip Tech.
    196.45 279.00(%)
  • Godfrey Phillips
    10,420.00 11,462.00(%)
  • Yes Bank
    20.38 24.40(%)
  • M & M
    3,292.60 3,430.10(%)
  • NTPC
    333.45 292.70(%)
  • TBO Tek
    1,609.20 2,000.00(%)
  • AU Small Finance
    716.05 840.95(%)
  • Larsen & Toubro
    3,606.35 3,963.00(%)
  • TCS
    3,087.75 2,992.05(%)
  • Bharat Electron
    381.05 435.95(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

ERIS Lifesciences Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 66197.0
  • ISIN : INE406M01024
1,779.90 9 (0.50%)
  • As on 03 Sep 2025 (EOD)

  • Today’s Low

    1,751.00

  • Today’s High

    1,799.00

  • Open

    1,774.80

  • Perv Close

    1,771.00

  • 52W Low

    1,097.20

  • 52W High

    1,910.00

Key Indicators

  • P/E(TTM)

    150.48

  • Mar.Cap (₹Cr.)

    24,122.22

  • Div & Yield %

    0.41

  • Book Value(₹)

    184.64

  • Debt-Equity Ratio

    0.50

  • AGM Date

    03-Sep-2025

  • EPS

    11.77

  • P/E Ratio

    150.48

Financials Ratios

  • Debt-Equity Ratio

    0.76

  • Mar.Cap (₹Cr.)

    24,122.22

  • RONW (%)

    16.61

  • ROCE (%)

    12.06

Score Board

  • Equity (₹ in Cr.)

    13.62

  • BV (₹)

    184.60

  • Sales( ₹ in Cr.)

    1,704.03

  • NP (in Cr.)

    76.04

  • NP Var(%)

    -74.0

  • Div%

    735.0

  • CPS (₹)

    18.90

  • EPS (₹)

    5.60

  • Traded Value (₹ in Lakhs)

    24,124.95

  • 52 Week High

    1,910.00

  • 52 Week Low

    1,097.20

  • Price BSE

    1771.0

  • Price NSE

    1,771.00

  • Market Capital( in Cr.)

    24,124.95

  • P/C Ratio

    93.60

  • P/E Ratio

    317.20

  • Price Vs.BV

    5.60

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 1,704.03 1,528.28 1,340.37 1,215.73 1,108.83 1,020.23
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 1,704.03 1,528.28 1,340.37 1,215.73 1,108.83 1,020.23
Other Income 35.51 34.83 17.26 28.99 10.00 14.73
Stock Adjustments 43.54 13.15 -8.50 -2.49 12.57 -17.47
Total Income 1,783.08 1,576.26 1,349.13 1,242.23 1,131.40 1,017.49
EXPENDITURE :            
Raw Materials 542.79 293.31 227.88 197.16 211.08 146.88
Power and Fuel Cost 4.10 4.46 4.41 4.01 3.89 4.54
Employee Cost 361.92 331.67 252.52 220.11 207.02 191.73
Other Manufacturing Expenses 22.35 16.80 11.50 7.47 7.16 10.62
Selling and Administration Expenses 223.80 319.27 242.67 215.51 181.66 219.34
Miscellaneous Expenses 106.06 122.10 87.78 84.93 93.13 73.93
Employee Benefit Expenses 361.92 331.67 252.52 220.11 207.02 191.73
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,261.02 1,087.61 826.75 729.18 703.93 647.04
Operating Profit 522.06 488.65 522.38 513.04 427.47 370.44
Interest 220.24 57.42 20.81 3.05 0.94 1.97
Gross Profit 301.82 431.23 501.57 509.99 426.53 368.47
Depreciation 181.77 102.39 64.66 51.46 37.64 44.88
Profit Before Tax 120.05 328.84 436.91 458.53 388.89 323.59
Current Tax 21.98 57.64 76.50 80.17 70.18 57.49
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 20.68 -28.52 -37.59 -38.83 -31.90 -25.17
Reported Net Profit 77.39 299.72 398.01 417.19 350.61 291.27
Extraordinary Items 1.35 2.79 5.17 -1.72 2.33 4.49
Adjusted Net Profit 76.04 296.93 392.84 418.91 348.28 286.78
Adjustment below Net Profit -2.84 -2.76 -0.15 -1.01 -1.28 -100.21
P & L Balance brought forward 2,487.17 2,190.21 1,892.28 1,557.74 1,283.09 1,139.01
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 100.06 0.00 99.93 81.65 74.68 46.98
P & L Balance carried down 2,461.66 2,487.17 2,190.21 1,892.28 1,557.74 1,283.09
Dividend 0.00 0.00 99.93 81.65 74.68 38.97
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 735.00 0.00 735.00 601.00 550.00 287.00
Dividend Per Share(Rs) 7.35 0.00 7.35 6.01 5.50 2.87
Earnings Per Share-Unit Curr 5.68 22.04 29.27 30.69 25.82 21.45
Earnings Per Share(Adj)-Unit Curr 5.68 22.04 29.27 30.69 25.82 21.45
Book Value 184.65 185.59 163.39 141.11 116.03 95.72
Book Value(Adj)-Unit Curr 184.65 185.59 163.39 141.11 116.03 95.72

Shareholding Pattern

  • Promoter Group

    54.84%

  • Public Share Holding

    45.17%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 74,683,744 54.84 74,683,744 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 74,683,744 54.84 74,683,744 5
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 10 0.00 10 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 3 0.00 3 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 11,436,410 8.40 11,436,410 143
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 874,352 0.64 874,352 8
Mutual Funds / UTI 22,850,386 16.78 22,850,386 23
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 1,028,508 0.76 1,028,508 17
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 36,189,669 26.57 36,189,669 193
2] Non Institution
Bodies Corporate 466,737 0.34 466,737 285
Clearing Members 438 0.00 438 5
Directors of their Relatives 675 0.00 675 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 233,625 0.17 233,625 1,267
Foreign Non Institution Other 11,965,882 8.79 11,965,882 1
Hindu Undivided Families 105,011 0.08 105,011 1,053
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 9,000,345 6.61 9,000,345 6
Individuals holding nominal share capital up to Rs. 1 lakh 3,420,018 2.51 3,420,018 49,365
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 55,493 0.04 55,493 2
Sub Total 25,323,912 18.59 25,323,912 52,027
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 136,197,325 100.00 136,197,325 52,225

Company Background

ERIS Lifesciences LtdPharmaceuticals - Indian - Formulations

  • ERIS Lifesciences Ltd
  • BSE Code : 66197.0
  • ISIN : INE406M01024

  • Incorporation Year

    2007

  • Registered Office

    8th Floor Commerce House -IV
    Prahladnagar 100 FT Road, Ahmedabad,
    Gujarat-380015

  • Telephone

    91-79-30451000

  • FAX

    91-79-48903474

  • Chairman

    Amit Indubhushan Bakshi

  • Managing Director

    Amit Indubhushan Bakshi

  • Company Secretary

    Milind Talegaonkar

  • Auditor

    Deloitte Haskins & Sells LLP

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

ERIS Lifesciences Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
ERIS Lifescience 1,771.20 1,733.26 1,697.75 150.48 6.83
Abbott India 32,356.30 6,684.73 6,409.15 47.34 44.95
Astrazeneca Phar 8,937.85 1,756.92 1,716.29 121.87 32.94
P & G Health Ltd 6,321.25 944.52 934.17 34.91 40.23
Glaxosmi. Pharma 2,749.15 3,866.05 3,723.49 49.44 58.72
Cipla 1,568.95 20,029.57 19,044.85 23.45 21.40
Amrutanjan Healt 729.20 469.50 451.82 38.66 21.89
Guj. Themis Bio. 376.95 152.47 150.80 92.16 27.21
Fermenta Biotec. 328.45 442.21 430.53 10.90 17.61
Bliss GVS Pharma 159.40 703.42 667.20 23.83 9.16
Ambalal Sarabhai 32.71 19.33 4.04 17.13 2.10